search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
News


Remote symptom reporting systems may reduce waiting lists Hope for treatment


Digital systems for patients to monitor and report symptoms remotely may offer a solution to reduce outpatient waiting lists, according to a new review published by the Journal of the Royal Society of Medicine. The review, led by researchers from the Centre


for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, at the University of Birmingham, looked at international examples of the use of electronic patient-reported outcome (ePRO) systems to triage clinical care. ePROs allow patients to fill out questionnaires at home or location of their choice, with the results sent back to the clinician in near real-time to use in clinical decision-making. Studies of various groups of patients, including those with epilepsy, sleep apnoea, type 1 diabetes, cancer, rheumatoid arthritis and HIV, were included in the review. In Denmark, Ambuflex – a generic ePRO system – has been used in over 40,000 patients across a range of chronic conditions, and has led to substantial reductions in outpatient appointments. In epilepsy clinics, the system led to reductions of up to 48% in in-person outpatient appointments. Lead author, Dr. Lee Aiyegbusi, associate


professor and deputy director at CPROR, said: “The use of PROs is well established in research settings to evaluate the effectiveness, cost-effectiveness and tolerability of interventions from a patient perspective. Clinicians are now interested in using patient-level symptom reporting for the clinical


for strokes linked to dementia


Two cheap and common drugs could be re- purposed as the first specific treatment for people who experience a type of stroke linked to nearly half of all dementias, according to the results of new research. A clinical trial run by the University of


management of individual patients in routine practice.” The review provides evidence to support the implementation of ePRO systems for outpatient care, including significant reductions in outpatient appointments without compromising patient outcomes or satisfaction with care. Dr. Aiyegbusi said: “ePROs for outpatient care could facilitate the tailoring of care to patient needs. Stable patients can be monitored remotely using ePROs, thereby avoiding unnecessary check- ups in outpatient clinics and associated costs, such as travel and time off work, without lowering the quality of treatment. This efficient use of scarce healthcare resources could free up outpatient clinics for patients with high symptom burden or concerning symptoms, so they can be seen more quickly.”


Nottingham and University of Edinburgh and funded by the British Heart Foundation has shown that isosorbide mononitrate and cilostazol, which are already used to treat other heart and circulatory diseases, can safely and effectively improve the debilitating outcomes people experience after lacunar stroke, particularly when they’re used in combination. The trial results were presented at the American Heart Association International Stroke Conference. After one year, participants that took both drugs were nearly 20% less likely to have problems with their thinking and memory compared to the group that did not take either drug. They were also more independent and reported a better quality of life. Those who took isosorbide mononitrate were also less likely to have had further strokes at one year. The drugs could be available as a treatment for lacunar strokes within five years, if the results are confirmed in further trials.


Up


The Oxford Up is suitable for those who require assistance when standing but are able to contribute effort to the process. By encouraging user participation, the Up can play a key role in rehabilitation, mobilisation and independence in acute care and nursing facilities.


Safe working load 200kg / 31st / 440Ibs Disassembles for storage/transportation Multi-point, contoured push handle Contoured swing-away seat pads Simple on-going maintenance Standard 5 year warranty


Contact Joerns Healthcare to find out more: (T) 0344 811 1158


12 www.clinicalservicesjournal.com I March 2023


(E) info@joerns.co.uk


(W) Joerns.co.uk


NEW FOR 2023!


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64